Putnam FL Investment Management Co. raised its holdings in Aetna Inc (NYSE:AET) by 218.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,472 shares of the company’s stock after buying an additional 40,139 shares during the period. Putnam FL Investment Management Co.’s holdings in Aetna were worth $10,548,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of the business. Price Capital Management Inc. acquired a new stake in Aetna in the fourth quarter valued at $1,602,000. ING Groep NV increased its position in shares of Aetna by 165.6% during the fourth quarter. ING Groep NV now owns 31,006 shares of the company’s stock worth $5,593,000 after purchasing an additional 19,332 shares in the last quarter. Gamble Jones Investment Counsel acquired a new stake in shares of Aetna during the fourth quarter worth about $225,000. Kassirer Asset Management Corp acquired a new stake in shares of Aetna during the fourth quarter worth about $1,524,000. Finally, AT Bancorp acquired a new stake in shares of Aetna during the fourth quarter worth about $2,509,000. Institutional investors own 87.41% of the company’s stock.
A number of research firms have recently commented on AET. Cantor Fitzgerald reiterated a “neutral” rating and set a $175.00 target price on shares of Aetna in a research report on Monday, October 23rd. Citigroup lifted their target price on Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research report on Thursday, November 2nd. BMO Capital Markets lifted their target price on Aetna from $175.00 to $200.00 and gave the stock a “market perform” rating in a research report on Friday, October 27th. Deutsche Bank upgraded Aetna from a “hold” rating to a “buy” rating and lifted their target price for the stock from $195.00 to $212.00 in a research report on Monday, January 22nd. Finally, Piper Jaffray Companies reiterated a “hold” rating and set a $187.00 target price on shares of Aetna in a research report on Friday, November 3rd. Ten equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Aetna currently has a consensus rating of “Buy” and an average target price of $185.94.
Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.18 by $0.07. The firm had revenue of $14.74 billion for the quarter, compared to analysts’ expectations of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The firm’s revenue for the quarter was down 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.08 EPS. equities analysts expect that Aetna Inc will post 10.99 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Thursday, January 11th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.10%. The ex-dividend date of this dividend was Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is presently 34.78%.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.